Reliable biotech news right now? BioTech Health X offers you the latest most reliable biotechnology news including breaking news on the latest biotechnology research, emerging companies, biotech acquisitions, funding deals and other industry analysis. BioTech Health X coverage includes a wide range of life sciences industry research including therapeutics, Pharma, cell therapy, others. Companies & researchers in the biotechnology business focus on developing drugs that could help to cure disease like cancer, DNA, Alzheimer’s and other medical related and genetic conditions. New cell therapies and modern research technologies have been developed allowing a company in the space to gather new data through trial research as they search for what could be the cure.

Toyobo Co., Ltd. has launched a major U.S. marketing initiative for Nerbridge TM (“the product”, hereafter), a conduit for peripheral nerve regeneration. On January 11, 2022, Toyobo kicked off the sales promotion campaign at a conference jointly held in Carlsbad, California, by three societies – the American Association for Hand Surgery (AAHS), the American Society for Peripheral Nerve (ASPN) and the American Society for Reconstructive Microsurgery (ASRM). The campaign is being conducted in partnership with the exclusive U.S. distributor of Nerbridge TM, Synovis Micro Companies Alliance, Inc. (hereafter Synovis), a subsidiary of Baxter International Inc., a global medtech leader. Toyobo plans to enhance the production capacity of the product by the end of 2025 as well as expanding the scope of its clinical applications. To respond to the increasing demand expected for nerves conduits in the U.S. and elsewhere in the world, Toyobo will strengthen its production and sales capacities, thus becoming the leading company in the nerve conduit business field.

Miller shared that CureDuchenne provided early funding to a large percentage of companies in the DMD space that are now in the clinical trial stage. Our vision is our name: to cure Duchenne, she said. Our goal is to uncover, fund and de-risk early science. By finding the technology that’s most likely to work for Duchenne, the company is filling the therapeutic pipeline. Miller makes a point to sit in on the Department of Defense’s Congressionally Directed Medical Research Programs, and stated that CureDuchenne is the largest funder of DMD research outside of the federal government. She described the softer side of the company, outlining its commitment to providing community support. One thing that is really important to us is providing hope to the families. We do that by highlighting and celebrating things that our young men with Duchenne can do. We focus on their accomplishments and how they’re continually raising the bar in terms of their achievements.

Our coverage spans research at the university level to Leibniz Institute Sagol Center to Hans Knöll Institute, infection biology to children with rare gene diseases, to the latest new infection that may arise like the risk of a global virus BioTech Health X keeps you up to date with news as it is revealed. Our team helps describe and characterize the new method of treatments like the promising nature of the COVID 19 vaccine. Breakthrough drugs are being made by various research team around the world and the environment in which we live is ever changing. Read more details on https://biotechhealthx.com/.

Physical disability can be very traumatic for a human being. Irrespective of the cause of the disability, it has a deep psychological effect on people’s minds. Since long there have been attempts to recreate the lost limbs or legs. There are two types of passive prosthetics – static and adjustable. In recent years, adjustable passive prosthetics have gained huge popularity among people due to its superior adjustment abilities. Several recognized organizations such as the International Committee of the Red Cross are now actively participating in the production of such passive prosthetics. They are also working in spreading the awareness about the benefits of using these passive prosthetics in developing countries such as Nepal, India, China, and New Zealand among others.